abstract |
An object of the present invention is to provide a PSF1-derived peptide useful for specific immunotherapy for cancer patients. The present invention provides a PSF1-derived peptide, a peptide that induces CTL, and a pharmaceutical composition for treating or preventing cancer containing the peptide of the present invention. |